LOXL2 and clear cell renal carcinoma: However, in clear cell renal cell carcinoma, the lncRNA myocardial infarction-associated transcript (MIAT) binds to and inhibits miR-29c action on LOXL2 [83], while in osteosarcoma, the lncRNA human major histocompatibility complex p5 (HCP5) neutralises the action of miR-29b [84].